BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ran J, Zhou J. Targeted inhibition of histone deacetylase 6 in inflammatory diseases. Thorac Cancer 2019;10:405-12. [PMID: 30666796 DOI: 10.1111/1759-7714.12974] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Mueller AL, Payandeh Z, Mohammadkhani N, Mubarak SMH, Zakeri A, Alagheband Bahrami A, Brockmueller A, Shakibaei M. Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies. Cells 2021;10:3017. [PMID: 34831240 DOI: 10.3390/cells10113017] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Xie L, Huang J, Li X, Dai L, Lin X, Zhang J, Luo J, Zhang W. Generation of a homozygous HDAC6 knockout human embryonic stem cell line by CRISPR/Cas9 editing. Stem Cell Research 2019;41:101610. [DOI: 10.1016/j.scr.2019.101610] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
3 Yang K, Wu H, Zhang Z, Leisten ED, Nie X, Liu B, Wen Z, Zhang J, Cunningham MD, Tang W. Development of Selective Histone Deacetylase 6 (HDAC6) Degraders Recruiting Von Hippel-Lindau (VHL) E3 Ubiquitin Ligase. ACS Med Chem Lett 2020;11:575-81. [PMID: 32292566 DOI: 10.1021/acsmedchemlett.0c00046] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
4 Cao Z, Gu Z, Lin S, Chen D, Wang J, Zhao Y, Li Y, Liu T, Li Y, Wang Y, Lin H, He B. Attenuation of NLRP3 Inflammasome Activation by Indirubin-Derived PROTAC Targeting HDAC6. ACS Chem Biol 2021;16:2746-51. [PMID: 34860497 DOI: 10.1021/acschembio.1c00681] [Reference Citation Analysis]
5 Dawood M, Elbadawi M, Böckers M, Bringmann G, Efferth T. Molecular docking-based virtual drug screening revealing an oxofluorenyl benzamide and a bromonaphthalene sulfonamido hydroxybenzoic acid as HDAC6 inhibitors with cytotoxicity against leukemia cells. Biomed Pharmacother 2020;129:110454. [PMID: 32768947 DOI: 10.1016/j.biopha.2020.110454] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
6 Markazi A, Bracci PM, McGrath M, Gao SJ. Pseudomonas aeruginosa Stimulates Inflammation and Enhances Kaposi's Sarcoma Herpesvirus-Induced Cell Proliferation and Cellular Transformation through both Lipopolysaccharide and Flagellin. mBio 2020;11:e02843-20. [PMID: 33173008 DOI: 10.1128/mBio.02843-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Yussuf Khamis M, Wu HP, Ma Q, Li YH, Ma LY, Zhang XH, Liu HM. Overcome the tumor immunotherapy resistance by combination of the HDAC6 inhibitors with antitumor immunomodulatory agents. Bioorg Chem 2021;109:104754. [PMID: 33677416 DOI: 10.1016/j.bioorg.2021.104754] [Reference Citation Analysis]
8 Zhang Z, Li Q, Du X, Liu M. Application of electrochemical biosensors in tumor cell detection. Thorac Cancer 2020;11:840-50. [PMID: 32101379 DOI: 10.1111/1759-7714.13353] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
9 Cao Y, Chen M, Dong D, Xie S, Liu M. Environmental pollutants damage airway epithelial cell cilia: Implications for the prevention of obstructive lung diseases. Thorac Cancer 2020;11:505-10. [PMID: 31975505 DOI: 10.1111/1759-7714.13323] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
10 Yan S, Wei X, Jian W, Qin Y, Liu J, Zhu S, Jiang F, Lou H, Zhang B. Pharmacological Inhibition of HDAC6 Attenuates NLRP3 Inflammatory Response and Protects Dopaminergic Neurons in Experimental Models of Parkinson's Disease. Front Aging Neurosci 2020;12:78. [PMID: 32296327 DOI: 10.3389/fnagi.2020.00078] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
11 Ghiboub M, Elfiky AMI, de Winther MPJ, Harker NR, Tough DF, de Jonge WJ. Selective Targeting of Epigenetic Readers and Histone Deacetylases in Autoimmune and Inflammatory Diseases: Recent Advances and Future Perspectives. J Pers Med 2021;11:336. [PMID: 33922725 DOI: 10.3390/jpm11050336] [Reference Citation Analysis]
12 Vergani B, Sandrone G, Marchini M, Ripamonti C, Cellupica E, Galbiati E, Caprini G, Pavich G, Porro G, Rocchio I, Lattanzio M, Pezzuto M, Skorupska M, Cordella P, Pagani P, Pozzi P, Pomarico R, Modena D, Leoni F, Perego R, Fossati G, Steinkühler C, Stevenazzi A. Novel Benzohydroxamate-Based Potent and Selective Histone Deacetylase 6 (HDAC6) Inhibitors Bearing a Pentaheterocyclic Scaffold: Design, Synthesis, and Biological Evaluation. J Med Chem 2019;62:10711-39. [DOI: 10.1021/acs.jmedchem.9b01194] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 5.7] [Reference Citation Analysis]
13 Li J, Yu M, Fu S, Liu D, Tan Y. Role of Selective Histone Deacetylase 6 Inhibitor ACY-1215 in Cancer and Other Human Diseases. Front Pharmacol 2022;13:907981. [DOI: 10.3389/fphar.2022.907981] [Reference Citation Analysis]
14 Dong D, Xie W, Liu M. Alteration of cell junctions during viral infection. Thorac Cancer 2020;11:519-25. [PMID: 32017415 DOI: 10.1111/1759-7714.13344] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
15 Kwon Y, Choi Y, Kim M, Jeong MS, Jung HS, Jeoung D. HDAC6 and CXCL13 Mediate Atopic Dermatitis by Regulating Cellular Interactions and Expression Levels of miR-9 and SIRT1. Front Pharmacol 2021;12:691279. [PMID: 34588978 DOI: 10.3389/fphar.2021.691279] [Reference Citation Analysis]
16 Kurohara T, Tanaka K, Takahashi D, Ueda S, Yamashita Y, Takada Y, Takeshima H, Yu S, Itoh Y, Hase K, Suzuki T. Identification of Novel Histone Deacetylase 6-Selective Inhibitors Bearing 3,3,3-Trifluorolactic Amide (TFLAM) Motif as a Zinc Binding Group. Chembiochem 2021. [PMID: 34224197 DOI: 10.1002/cbic.202100255] [Reference Citation Analysis]
17 Barone S, Cassese E, Alfano AI, Brindisi M, Summa V. Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology. J Med Chem 2022. [PMID: 35148101 DOI: 10.1021/acs.jmedchem.1c02067] [Reference Citation Analysis]
18 Wong XK, Yeong KY. A Patent Review on the Current Developments of Benzoxazoles in Drug Discovery. ChemMedChem 2021. [PMID: 34289258 DOI: 10.1002/cmdc.202100370] [Reference Citation Analysis]
19 Yang J, Li D, Zhou J. Histone Deacetylase 6 as a Therapeutic Target in B cell-associated Hematological Malignancies. Front Pharmacol 2020;11:971. [PMID: 32676030 DOI: 10.3389/fphar.2020.00971] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]